Dana Carroll on Sigma Life Science’s role in genome editing
Welcome to the second blog in our series about Dr. Dana Carroll at the University of Utah! Dr. Carroll helped develop the Zinc Finger Nuclease (ZFN) technology for targeted genome editing offered by Sigma Life Science as CompoZr® ZFN.
In the following video, we asked Dr. Carroll to expand upon his thoughts about Sigma Life Science’s role in enabling genome editing through the use of ZFN technology. He kindly praises the scientists of Sigma who have worked closely with Sangamo Biosciences to develop the best ZFNs available, and for taking this technology further by developing genetically modified cell lines and rodent models.
He also challenged us to continue making the nucleases more accessible to the larger scientific community. We have been working hard to meet his challenge. Access our CompoZr ZFNs, without breaking the bank.
